Display options
Cite
Stanić Benić M, Mirošević Skvrce N, Božina N. The Role of Pharmacogenetic Testing in the Evaluation of Drug-Induced Liver Injury. Clin Ther. 2016;38(10):e24-e25doi: 10.1016/j.clinthera.2016.07.145.
Stanić Benić, M., Mirošević Skvrce, N., & Božina, N. (2016). The Role of Pharmacogenetic Testing in the Evaluation of Drug-Induced Liver Injury. Clinical therapeutics, 38(10), e24-e25. https://doi.org/10.1016/j.clinthera.2016.07.145
Stanić Benić, M, et al. "The Role of Pharmacogenetic Testing in the Evaluation of Drug-Induced Liver Injury." Clinical therapeutics vol. 38,10 (2016): e24-e25. doi: https://doi.org/10.1016/j.clinthera.2016.07.145
Stanić Benić M, Mirošević Skvrce N, Božina N. The Role of Pharmacogenetic Testing in the Evaluation of Drug-Induced Liver Injury. Clin Ther. 2016 Oct 06;38(10):e24-e25. doi: 10.1016/j.clinthera.2016.07.145. PMID: 27673641.
Copy Download .nbib Format: NLM
Share it on

Clin Ther. 2016 Oct 06;38(10):e24-e25. doi: 10.1016/j.clinthera.2016.07.145.

The Role of Pharmacogenetic Testing in the Evaluation of Drug-Induced Liver Injury.

Clinical therapeutics

M Stanić Benić, N Mirošević Skvrce, N Božina

Affiliations

  1. Clinical Hospital Centre Rijeka, Rijeka, Croatia.
  2. Agency for Medicinal Products and Medical Devices, Zagreb, Croatia.
  3. University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.

PMID: 27673641 DOI: 10.1016/j.clinthera.2016.07.145

[No abstract available.]

Publication Types